Jocelyn Eason, General Manager of Science, Food 13/CEN/144 Approve Beneficial effects of food on health Dr Juliet Ansell Observational Innovation, Plant & Food Research Ltd Dr Stephen 13/CEN/146 Approve ACCT007: Rap-CV Auckland District Health Intervention Laughton Dr Mark Auckland District Health 13/CEN/150 Approve STEP-UP Intervention O’Carroll Board Zenith Technology Oxycodone 5 mg bioequivalence study Corporation Limited,Zenith 13/CEN/152 Approve Dr Noelyn Hung Intervention conducted under fasting conditions Technology Corporation Limited Dr Mark Alison Masters, Clinical 13/CEN/153 Approve Psychotropic Obesity Observational Observational Huthwaite Director, Neurocognitive impairment in long term 13/CEN/154 Decline Dr Rachael Dr Evans Observational paediatric liver transplant recipients COG ALTE07C1 - Neuropsychological, Dr Stephen Auckland District Health 13/CEN/162 Approve Social, Emotional, and Behavioural Dr Amanda Lyver Observational Laughton Board Outcomes in Children with Cancer Dr Stephen 13/CEN/163 Approve COG ACNS0822 Intervention Laughton Dr Lochie 13/CEN/168 Provisionally approve COG ASCT1221 Intervention Teague Injury and NeuroAid Supplementation Professor Valery 13/CEN/175 Approve Intervention (BRAINS) Feigin study comparing how fast the drug “A GS-5816 is cleared from the body, in Dr Richard 13/CEN/177 Approve Chris Taylor, CCST Intervention healthy adults and in adults with severely Robson reduced kidney function” An interventional looking at caregiver 13/CEN/181 Decline Dr Bhamini BOPDHB Intervention education in managing BPSD.
13/CEN/144 Approve Beneficial effects of food on health Dr Juliet Ansell Jocelyn Eason, General Manager of Science, Food Innovation, Plant & Food Research Ltd Observational 13/CEN/146 Approve ACCT007: Rap-CV Dr Stephen Laughton Auckland District Health Intervention 13/CEN/150 Approve STEP-UP Dr Mark O’Carroll Auckland District Health Board Intervention 13/CEN/152 Approve Oxycodone 5 mg bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention 13/CEN/153 Approve Psychotropic Obesity Observational Dr Mark Huthwaite Alison Masters, Clinical Director, Observational 13/CEN/154 Decline Neurocognitive impairment in long term paediatric liver transplant recipients Dr Rachael Dr Evans Observational 13/CEN/162 Approve COG ALTE07C1 - Neuropsychological, Social, Emotional, and Behavioural Outcomes in Children with Cancer Dr Stephen Laughton Dr Amanda Lyver Auckland District Health Board Observational 13/CEN/163 Approve COG ACNS0822 Dr Stephen Laughton Intervention 13/CEN/168 Provisionally approve COG ASCT1221 Dr Lochie Teague Intervention 13/CEN/175 Approve Injury and NeuroAid Supplementation (BRAINS) Professor Valery Feigin Intervention 13/CEN/177 Approve “A study comparing how fast the drug GS-5816 is cleared from the body, in healthy adults and in adults with severely reduced kidney function” Dr Richard Robson Chris Taylor, CCST Intervention 13/CEN/181 Decline An interventional looking at caregiver education in managing BPSD. Dr Bhamini BOPDHB Intervention
central-regional-ethics-committee-annual-report-2013.docx